A world where people in low- and middle-income countries have rapid access to affordable and appropriate HIV, hepatitis C and tuberculosis treatments.


Our mission is to increase access and promote innovation in the fields of HIV, hepatitis C and tuberculosis treatments through voluntary licensing and patent pooling. Founded in 2010 by Unitaid, the MPP works with a range of partners – industry, civil society, international organisations, patient groups and governments – to prioritise and license new and existing medicines for low- and middle-income countries.

This website uses cookies to ensure you get the best experience on our website. Learn More